Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy
PHASE2CompletedINTERVENTIONAL
Enrollment
15
Participants
Timeline
Start Date
January 31, 2007
Study Completion Date
October 31, 2007
Conditions
HypogonadismChronic Obstructive Pulmonary Disease
Interventions
DRUG
Fispemifene
once daily for 4 weeks
All Listed Sponsors
lead
QuatRx Pharmaceuticals Company
INDUSTRY
NCT01061970 - Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy | Biotech Hunter | Biotech Hunter